ICD-10-PCS Code Range for Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

ICD-10-PCS Code Range for Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products is medical classification list by Centers for Medicare and Medicaid Services (CMS).

ICD-10-PCS code range (3E0), contains ICD-10-PCS codes for Administration, Physiological Systems and Anatomical Regions, Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Subscribe to Codify and get the code details in a flash.

PCS Tables

3E0

3 Administration
E Physiological Systems and Anatomical Regions
0 Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Body System / Region Approach Substance Qualifier
Character 4 Character 5 Character 6 Character 7
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
B Anesthetic Agent
K Other Diagnostic Substance
M Pigment
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
A Anti-Infective Envelope
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
A Anti-Infective Envelope
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
4 Serum, Toxoid and Vaccine
Qualifier (Character 7)
0 Influenza Vaccine
Z No Qualifier
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
J Other Hormone
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
4 Serum, Toxoid and Vaccine
Qualifier (Character 7)
0 Influenza Vaccine
Z No Qualifier
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Q Glucarpidase
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Q Glucarpidase
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
K Other Diagnostic Substance
P Platelet Inhibitor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
A Bone Marrow
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
A Bone Marrow
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
M Pigment
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
R Antiarrhythmic
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
D Nitric Oxide
F Other Gas
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Y Hyperthermic
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
L Sperm
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
V Hormone
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
Q Fertilized Ovum
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
L Sperm
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
V Hormone
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
Q Fertilized Ovum
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
A Stem Cells, Embryonic
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
0 Open
Substance (Character 6)
A Stem Cells, Embryonic
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
0 Open
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
A Stem Cells, Embryonic
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
S Epidural Space
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
T Peripheral Nerves and Plexi
X Cranial Nerves
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
T Peripheral Nerves and Plexi
X Cranial Nerves
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
U Joints
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
U Joints
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
U Joints
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
V Bones
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas

December 31, 1969
Released earlier than usual the fiscal year FY 2022 ICD10CM Official Guidelines for Coding and Reporting became available online Monday July 12 and include instructions for assigning novel code U09.9 ... [ Read More ]
December 31, 1969
The AAPC Social Hour on Facebook Live July 15 at 11 a.m. MT 1 p.m. ET focused on career paths and certifications. Moderator and AAPC Social Media Manager Alex McKinley was joined by National Advisory ... [ Read More ]
December 31, 1969
Proposed rule improves payment rates incentives and ESRD treatment choices. Disadvantaged Medicare patients suffer from endstage renal disease ESRD at higher rates and are also more likely to be readm... [ Read More ]
December 31, 1969
Interim final rule lays groundwork for implementing No Surprises Act by 2022. On July 1 the U.S. Department of Health and Human Services HHS Labor and Treasury and the Office of Personnel Management i... [ Read More ]
December 31, 1969
Who has time to read all those wordy news releases and transmittals Here8217s news you can use in under 5 minutes. Catch up on the latest coding and billing updates that will affect your Medicare Part... [ Read More ]
Hello everyone! Having a discussion about pulling different doses from the vial. Can you pull 20mg from the vial and still use the same NDC number?... [ Read More ]
My boss says we shouldn't use a 79 modifier to bill for an aspiration of the knee in the global period of a total knee replacement. I was taught that an unplanned procedure in a post op period was not... [ Read More ]
We are having trouble with Anthem paying this code and was wondering if anyone else was struggling to get 15777 paid. The Mue is one but the code description does allow for bi-lateral procedure. When... [ Read More ]
Hi all - I am new to behavioral health coding and would like to know if DM with CKD can/should be the primary and secondary dx for a visit when a patient sees a psychiatrist. The provider does couns... [ Read More ]
I’m a coder but haven’t worked in a specialist practice before, and I have a question regarding billing related to an in-office procedure. Someone I know had a 12-core prostate biopsy in his urol... [ Read More ]
If a patient is seen and treated at one facility and the treating physician is working under that group's credentials and Place of Service then the treating physician leaves the practice and is now bi... [ Read More ]
Is there a new CPT code for COVID-19 POC Rapid Test?... [ Read More ]
I understand telemedicine and telehealth guidelines are temporary due to covid. Has anyone out there any knowledge on changes as of August or upcoming changes or restrictions on telemed use for ENT sp... [ Read More ]
Can someone help me with this. I was thinking 31528 for one of the codes but I am just lost. Pre-op Diagnosis: Subglottic tracheal stenosis Post-op Diagnosis: same Procedure Performed:  Micros... [ Read More ]
One of our general surgeons performed a procedure on a pt back in May, 2021 that had a 90 global period. He was performing the service under contract at a different facility and they would have billed... [ Read More ]

Which Codify tool is right for you?

Call 844-334-2816 to speak with a Codify specialist now.